This post shows an overview of the presentations given during this edition. Some speakers have given permission to watch the presentation and/or download the PDF of the presentation. Click on the right link.
|Beyond 3D Printing
|Moderator: Pieter Hermans, Jakajima
|Banu Köse, Strategy Lead Research, Clinician Engineer Hub / Assistant Professor, Medipol University School of Engineering and Natural Sciences, on 'Building A Common Language Between Engineers and Clinicians for Healthcare System Innovation', Read more
|Ernst Jan Louwers, Founding partner, Louwers IP|Technology Advocaten, on 'Enabling collaborative innovation', Read more
|Arie Platschorre, Director, Technical Sales, SIMULIA, Dassault Systèmes, on 'Meeting the Process Challenges of Delivering New Therapeutics', Read more
|Bart Verreydt, Chief Commercial Officer, Iristick, on 'Smart Glasses for medical applications', on 'How Extended reality (XR) and Smart Glasses can help advance healthcare', Read more
|Ger Janssen, Principal Scientist, Philips thought leader patient digital twin, Philips, on 'The value and use of patient digital twin in healthcare', Read more
If you are interested in the upcoming edition, have a look at the conference program and / or subscribe to our newsletter.
This conference is part of the 3D Medical Printing Series. Other topics during this series are 3D Bioprinting, 3D Medtech Printing, 3D Dental Printing and Beyond 3D Printing.
Sustainability and health are two of the global challenges recognized by UN. Electronics is the pillar that supports the innovation in these sectors. However, current electronic components are non-biodegradable and release toxins in environment, while the implanted electronics is not compatible with soft human tissues. The aim of my research is to overcome these challenges through i) development of novel electronic material library, and ii) next-generation devices with new form factors.
Continue reading “Reshaping Electronics for Healthcare sector”
Organs are complex systems, comprised of different tissues, proteins, and cells, which communicate to orchestrate a myriad of functions in our bodies. Technologies are needed to replicate these structures towards the development of new therapies for tissue and organ repair, as well as for in vitro 3D models to better understand the morphogenetic biological processes that drive organogenesis.
Continue reading “From Scaffold Design to Control Stem Cell Fate to Bioprinting”
Talking mouthguards, we see hygiene, safety and sustainability play an important role in the future. As this multimillion market is within reach, 3Dmouthguard achieved to produce over 500 mouthguards per day. Through additive manufacturing, the production capacity is limitless enabling to deliver constant quality within promised delivery times.
Continue reading “High volume 3Dprinting of mouthguards”
New technologies like bioprinting, predictive analysis and 3D printing of medical devices, braces etc. may lead to shifting positions and responsibilities. Players like hospitals and doctors may turn into factories but do not realise their changed position. Ernst-Jan Louwers will discuss the rules of the game in the highly regulated medical market, paradigm shifts and concerns in supply chain, warranties, liabilities and IP.
Continue reading “Enabling collaborative innovation”
A clear unmet medical need exists for pediatric-centered drug formulations. Currently, it is often still necessary to either manipulate a marketed drug before it can be administered to a child, or to prepare an extemporaneous preparation by the pharmacist. As a highly flexible production technique, 3D printing can provide in this unmet need.
In this presentation, the product development of two active pharmaceutical ingredients, namely furosemide and sildenafil, will be presented.
Continue reading “3D printing tablets for individual pediatric patients: development of furosemide and sildenafil tablets”
In this presentation, we will discuss how 3D bioprinting technologies enable the fabrication of more reliable tissue models, which have wide application, including the development and validation of the efficacy of pharmaceutical products, screening of drug therapies and understanding of tissue development and oncology processes.
Continue reading “From cells to 3D tissues: Creating complex 3D tissue models using CELLINKs technologies”
Patient digital twins offer great opportunities in healthcare. After explaining the concept, several impactful practical examples showing the current status will be shared, plus an outlook on future exciting and impactful developments. A presentation by Ger Janssen, Head of the AI, Data Science & Digital twin department (a.i.); thought leader patient digital twin at Philips.
Continue reading “The value and use of patient digital twin in healthcare”
Aprecia continues its leadership position in the pharmaceutical application of 3D-Printing. Aprecia will be launching its two new platforms later this year that will provide additional benefits in early development FIH clinical as well as small and large scale commercial production. In this presentation, Aprecia will discuss the flexibility and precision these platform provide in delivering novel products to the market.
Continue reading “Enabling Novel Pharmaceutical Therapies through 3D-Printing”
In this presentation I would like to share with you the steps we at TNO and our partners are taking towards practical application of 3D pharmaprinting, and give an insight in how we envision to tackle the challenges still ahead. A presentation by Anton Aulbers, Senior consultant 3D Pharma printing at TNO.
Continue reading “3D Pharmaprinting at TNO, steps towards practical application”